Journal of Antimicrobial Chemotherapy (2000) 45, 871-875
© 2000 The British Society for Antimicrobial Chemotherapy
Brief reports |
Presence of ROB-1 ß-lactamase correlates with cefaclor resistance among recent isolates of Haemophilus influenzae
a Department of Medical Microbiology and b Faculty of Pharmacy, University of Manitoba; Departments of c Clinical Microbiology and d Medicine, Health Sciences Centre, Winnipeg, Manitoba, Canada
ß-Lactamase production in Canadian isolates of Haemophilus influenzae has remained relatively constant (2535%) over the last decade despite increasing cefaclor resistance (MIC
32 mg/L). TEM (294/324, 90.7%) and ROB-1 (30/324, 9.3%) prevalence rates among 324 isolates of H. influenzae obtained from across Canada in 19971998 were similar (P > 0.05) to previously published reports. However, 66.7% (26/39) of cefaclor-resistant isolates were ROB-1-positive (P < 0.001) and the remaining four ROB-1-positive isolates were cefaclor-intermediate (MIC 16 mg/L). Susceptibilities to loracarbef (P < 0.001) and cefprozil were also reduced in the presence of ROB-1 while the activities of cefuroxime, cefotaxime, cefixime and imipenem were similar in both TEM- and ROB-1-positive solates.
* Correspondence address. Department of Clinical Microbiology, Health Sciences Centre, MS673, 820 Sherbrook Street, Winnipeg, Manitoba R3A 1R9, Canada. Tel: +1-204-787-4683; Fax: +1-204-787-4699; E-mail: jkarlowsky{at}hsc.mb.ca
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. San Millan, J. A. Escudero, A. Catalan, S. Nieto, F. Farelo, M. Gibert, M. A. Moreno, L. Dominguez, and B. Gonzalez-Zorn {beta}-Lactam Resistance in Haemophilus parasuis Is Mediated by Plasmid pB1000 Bearing blaROB-1 Antimicrob. Agents Chemother., June 1, 2007; 51(6): 2260 - 2264. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tristram, M. R. Jacobs, and P. C. Appelbaum Antimicrobial Resistance in Haemophilus influenzae Clin. Microbiol. Rev., April 1, 2007; 20(2): 368 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sanbongi, T. Suzuki, Y. Osaki, N. Senju, T. Ida, and K. Ubukata Molecular Evolution of {beta}-Lactam-Resistant Haemophilus influenzae: 9-Year Surveillance of Penicillin-Binding Protein 3 Mutations in Isolates from Japan. Antimicrob. Agents Chemother., July 1, 2006; 50(7): 2487 - 2492. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Tristram and S. Nichols A multiplex PCR for {beta}-lactamase genes of Haemophilus influenzae and description of a new blaTEM promoter variant J. Antimicrob. Chemother., July 1, 2006; 58(1): 183 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Farrell, I. Morrissey, S. Bakker, S. Buckridge, and D. Felmingham Global distribution of TEM-1 and ROB-1 {beta}-lactamases in Haemophilus influenzae J. Antimicrob. Chemother., October 1, 2005; 56(4): 773 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Galan, M.-I. Morosini, M.-R. Baquero, M. Reig, and F. Baquero Haemophilus influenzae blaROB-1 Mutations in Hypermutagenic {Delta}ampC Escherichia coli Conferring Resistance to Cefotaxime and {beta}-Lactamase Inhibitors and Increased Susceptibility to Cefaclor Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2551 - 2557. [Abstract] [Full Text] [PDF] |
||||


